Medical Weight Loss, Backed by Science
PERSONALIZED CARE. EVIDENCE-BASED MEDICINE. MEANINGFUL RESULTS.
Weight management is more than willpower, calorie counting, or exercise. Body weight is regulated by complex interactions among hormones, appetite signaling, metabolism, genetics, and lifestyle.
At SKIM Medical Spa, we take a medical, evidence-based approach to weight management using advanced injectable therapies, including semaglutide and tirzepatide.
These medications target biological pathways involved in hunger, fullness, and food intake, helping eligible patients manage appetite and achieve clinically meaningful weight loss when combined with nutrition, physical activity, and ongoing medical care.
Our goal goes beyond the number on the scale. We focus on supporting healthier body composition, improving metabolic health, and building sustainable habits for long-term wellness.
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone released by the intestine in response to food. It plays an important role in regulating appetite, blood glucose, and digestive function.
GLP-1–based medications work by activating specific hormone receptors involved in the body's metabolic and appetite-regulating systems.
They can help:
Reduce hunger and food cravings by influencing appetite and satiety pathways in the brain.
Increase feelings of fullness to help patients feel satisfied with smaller portions.
Slow gastric emptying, particularly early in treatment, contributing to satiety.
Improve glucose regulation through glucose-dependent insulin secretion and reduced glucagon signaling.
Support clinically significant weight loss when used alongside healthy lifestyle modifications.
Unlike short-term diet trends, these medications address some of the underlying biological mechanisms that make weight management challenging.
How GLP-1–Based Medications Work
Our Medical Weight Loss Options
Semaglutide | GLP-1 Receptor Agonist
Semaglutide mimics the action of GLP-1, helping regulate hunger, satiety, and blood glucose. It is the active ingredient in Wegovy and Ozempic, although these branded products have different FDA-approved indications.
Tirzepatide | Dual GIP + GLP-1 Receptor Agonist
Tirzepatide targets two hormone receptors—GIP (glucose-dependent insulinotropic polypeptide) and GLP-1—to influence appetite, food intake, and glucose metabolism. It is the active ingredient in Zepbound and Mounjaro, which also have distinct FDA-approved indications.
In clinical trials, both medications have demonstrated substantial average weight reduction in eligible adults. Individual results vary according to the medication, dose, medical history, treatment duration, and lifestyle factors.
More Than Weight Loss. A Healthier You.
Achieving and maintaining a healthier weight can have benefits beyond appearance. For some patients, clinically meaningful weight reduction may improve blood pressure, glycemic control, mobility, and other obesity-related health markers.
At SKIM Medical Spa, your treatment plan is guided by individual health needs, treatment response, and tolerability—not a one-size-fits-all approach.
Your health. Your goals. Your personalized plan.
Schedule a medical weight loss consultation and discover whether GLP-1–based therapy may be appropriate for you.
FAQs
-
Most common side effects are nausea, vomiting, stomach upset, diarrhea, tiredness, dizziness, or constipation. Initial side effects usually lessens as you continue to use Semaglutide.
-
It’s crucial to know that semaglutide results don’t manifest right away. Having realistic expectations and attending all your treatment sessions will increase your chances of satisfactory results. Men and women who eat well, exercise, and stick to their treatment plans observe a stunning transformation.
One way to stay motivated and observe your progress is by taking before and after photos. Session after session, you’ll see how your body is reacting to the treatment.
Semaglutide is a promising option for those looking to lose weight. Its ability to suppress appetite, reduce cravings, and increase fullness can lead to faster weight loss. Those with Type-2 diabetes especially benefit from an extra perk—improved blood sugar control.
-
Semaglutide or tirzepatide is ideal for individuals with a body mass index (BMI) of 30 or greater or adults with a BMI of 27 and at least one complication related to body weight, such as hypertension, insulin resistance, high cholesterol, or heart disease.
-
Most patients will begin to see weight loss after their initial dose has increased one to two times, typically within a month.
-
Semaglutide or tirzepatide is injected just under the skin (subcutaneously), typically in your abdomen.
-
Despite semaglutide/tirzepatide being a good weight loss tool for many people, it's not for everyone. Certain people shouldn't take it:
-Pregnant or breastfeeding women
-People with a history of pancreatitis
-People with Type-1 diabetes
-People with an allergy to semaglutide (or any of its ingredients)
-People with Multiple Endocrine Neoplasia syndrome type 2
Always consult a medical professional before taking semaglutide. Be open and honest about any pre-existing conditions and allergies, so we can make sure it's a good fit before beginning treatment.